论文部分内容阅读
目的:回顾颈内动脉球囊闭塞试验(balloonocclusiontest,BOT)和颈内动脉(ICA)闭塞治疗海绵窦动脉瘤病例,评估BOT的安全性和有效性,并总结经验。方法:73例ICA海绵窦段动脉瘤患者,通过不可脱球囊暂时性闭塞ICA,作BOT,46例BOT阴性的海绵窦动脉瘤患者采用可脱性球囊永久性闭塞ICA治疗,观察其脑缺血并发症的发生率。结果:BOT的阳性率为26.4%,其中,女性为21.7%,男性为33.3%,女性患者左侧BOT阳性率高于右侧(P<0.05),但在男性不明显。与BOT相关并发症的发病率为2.7%,包括死亡1例。在BOT阴性患者中,永久性ICA闭塞后脑缺血的发病率为4.3%。结论:BOT是检测患者是否耐受ICA闭塞安全有效的方法。
Objective: To review the cases of cavernous sinus aneurysm treated by balloon occlusion test (BOT) and occlusion of internal carotid artery (ICA), evaluate the safety and efficacy of BOT, and summarize the experience. Methods: Totally 73 patients with ICA cavernous sinus aneurysm were treated with occlusive ICA for BOT and 46 patients with BOT-negative cavernous aneurysm by permanent occlusion of ICA. The incidence of ischemic complications. Results: The positive rate of BOT was 26.4%, of which 21.7% were women and 33.3% were male. The positive rate of BOT in the left side of female patients was higher than that of the right side (P <0.05), but not obvious in males. The incidence of complications associated with BOT was 2.7%, including 1 death. In BOT-negative patients, the incidence of cerebral ischemia after permanent ICA occlusion was 4.3%. CONCLUSIONS: BOT is a safe and effective method of testing patients for ICA occlusion.